McKinsey to pay $78M to health plans in opioid settlement

McKinsey and Company agreed to pay $78 million to health plans to settle allegations the consulting firm helped Purdue Pharma create misleading advertising campaigns for opioids, The Hill reported Dec. 30. 

Advertisement

The proposed settlement was filed in federal district court in California Dec. 29. It must be approved by a judge. 

The lawsuit was brought by a group of health insurers and company plans, The Hill reported. 

McKinsey has settled a series of lawsuits from states, local governments and Native American tribes. In 2021, the consulting firm paid $573 million to 47 states to settle allegations it advised Purdue Pharma to ramp up sales of OxyContin. 

In a previous statement, McKinsey said it continues to believe its previous work was lawful. The company stopped advising clients on any opioid-related business in 2019. 

At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.

Register to Attend Webinar

Read. Deleted. Ignored. What It Takes to Drive Behavior Change and Lower the Cost of Care

Tuesday, August 4
11:00 AM - 12:00 PM CDT

Presenters: Koleen Cavanaugh, Independence Blue CrossBukata Hayes, HMO Minnesota (Blue Plus)Nathan Foco, Select HealthTrish Cox, SCAN Health PlanJonas Puente, ZS Associates

Advertisement

Next Up in Payer

Advertisement

Comments are closed.